Today, we announced the completion of our Series C financing round, as well as the appointment of industry leader John A. Wagner, M.D., Ph.D. as our first Chief Medical Officer….
Read More
NEW YORK–(BUSINESS WIRE)–Koneksa, the leader in designing and validating digital biomarkers to accelerate drug development, announced today the completion of a $45M Series C financing round, led by AyurMaya, an...
Read More
Koneksa will invest in the continued development of its digital platform for integrating wearables, sensors, and other technologies on a global scale. Financing round was led by Spring Mountain Capital...
Read More
